The MPV17 gene helps mitochondria, the parts of cells that make energy, keep their own DNA stable. When it does not work properly, cells may struggle to make enough energy, especially in the liver, brain, and nerves. This gene plays an important role in tissues that need a lot of energy. Pathogenic variants can cause a rare inherited mitochondrial condition that may lead to liver disease, poor growth, weakness, nerve problems, and developmental delay, often starting in infancy or childhood.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. If you want to look at this topic more closely, you can find more in the LearnHub.
Overview
MPV17Gene function
What if the gene works
The MPV17 gene helps mitochondria, the cell’s energy makers, maintain their DNA. This supports steady energy production, especially in tissues with high energy needs.
Risk
What if the gene does not work
Variants in the MPV17 gene can impair mitochondrial energy production, leading to a condition that often affects the liver and nervous system. Effects range from severe early childhood liver failure and developmental problems to milder later-onset nerve symptoms.
Treatment
What does that mean for your treatment
Pathogenic variants in the MPV17 gene do not currently point to a gene-specific treatment or standard medication choice. Care is supportive and guided by the person’s symptoms and organ involvement rather than by MPV17 status itself.
Conditions associated with MPV17
Gene function
What if the gene works
Your cells need healthy mitochondria to keep energy flowing through daily tasks like muscle movement, liver work, and brain activity. The MPV17 gene supports this process inside the inner membrane of mitochondria, the small parts of cells that make energy. It is especially important for keeping mitochondrial DNA stable over time. This helps explain the MPV17 gene function in mitochondria and why it matters across the body.
MPV17 helps mitochondria maintain their own DNA, which carries instructions for proteins used in energy production. Stable mitochondrial DNA supports steady work inside these parts of the cell.
By supporting healthy mitochondria, MPV17 helps cells turn nutrients and oxygen into usable energy. This is part of normal MPV17 gene function in mitochondria, which helps many organs meet daily energy needs.
The MPV17 protein sits in the inner membrane of mitochondria, where it supports a stable environment for routine mitochondrial activity. That steady setting helps these cell structures carry out everyday energy related tasks.
What is a variant?
Within a gene, a genetic variant is a small change in the DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
MPV17 gene variants can make the MPV17 protein unstable, less active, or missing, which weakens a cell’s ability to maintain mitochondrial DNA, the small set of DNA inside its energy making parts. Some changes partly reduce this function, while more disruptive variants can cause a greater loss. In mitochondrial DNA depletion syndrome linked to the MPV17 gene, milder variants may be tied to later or less severe symptoms, while severe variants often lead to earlier, broader disease.
How variants are linked to conditions
Pathogenic variants in the MPV17 gene cause mitochondrial DNA depletion syndrome, hepatocerebral type, a rare inherited condition that often starts in infancy with liver disease and developmental or nerve related problems. In some families, especially among Navajo people, this MPV17 gene related condition has been described as Navajo neurohepatopathy. When the clinical picture fits, a disease causing variant in the MPV17 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene changes are a normal part of human biology and are widely found in the general population. Most variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MPV17, risk is driven mainly by inheritance: it is highest when both parents carry a harmful MPV17 variant and a child inherits both changed copies. There is not broadly confirmed evidence that diet, exercise, or other lifestyle factors meaningfully change the chance of having an MPV17-related condition.
Inheritance of MPV17 variants
MPV17-related conditions are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two changed copies of the MPV17 gene, one from each parent, to have the condition. Parents who each carry one variant are typically unaffected, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variants. This is the main answer to how MPV17 variants are inherited.
What does my MPV17 result mean for my family?
For families with an MPV17-related condition, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also have the condition or be carriers, so close relatives may want to learn whether the same gene change runs in the family. Children of someone with an MPV17-related condition will usually be carriers unless the other parent also carries an MPV17 change.
Genetic information
Genetic testing
How you find out about variants
Variants in the MPV17 gene are usually found with MPV17 genetic testing, using a blood sample, saliva sample, or cheek swab. The lab reads the gene's DNA code to look for changes and may test parents or other relatives to help show whether a variant helps explain a person's symptoms or family history.
When should I consider getting a genetic test?
Genetic testing for the MPV17 gene may be considered if a baby or child has unexplained liver failure, poor growth, low muscle tone, weakness, numbness, or other signs of a condition that affects how the body makes energy. It can also be helpful when a close family member has an MPV17 variant or a related inherited condition.
A genetic result is only one part of your health story
Genetic results can provide useful insight, yet the amount they reveal varies with the condition and the specific type of variant. How your body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result can give a clear answer. For topics such as medication response, these results may help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in DNA can change how a drug is absorbed, broken down, transported, or used by the body, which helps explain why the same treatment may work well for one person but less well for another. These inherited differences are common and can influence both how effective a medicine is and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medicines. By studying links between genes and medications, it aims to explain why the same treatment may work differently in different people. For many drugs, genes can influence both how powerfully a medicine works and how the body handles it. Understanding this can support more informed, personalized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the MPV17 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so any concerns about symptoms, treatment, or side effects are best discussed with your doctor or pharmacist.
History
MPV17 first came to attention through animal research in the 1990s, when scientists identified a related gene in mice with kidney problems, hearing changes, and loss of body pigment. Soon after, researchers found the human MPV17 gene and began comparing it with the mouse findings. From these first observations, research expanded steadily. In the 2000s, variants in the MPV17 gene were linked to inherited mitochondrial DNA depletion syndrome, especially forms affecting the liver and nervous system in children. That connection helped explain why some families had a pattern of early liver failure with neurologic symptoms that had previously been hard to classify. Over time, descriptions became more precise as genetic testing improved and more affected families were studied.